BioCentury | Jul 30, 2012
Clinical News

BPM 31543: Phase I started

...Berg Pharma began an open-label, U.S. Phase I trial to evaluate BPM 31543 applied to the scalp...
...in about 18 patients with metastatic breast cancer who are receiving paclitaxel. Patients will receive BPM 31543...
...3 months or until the end of chemotherapy treatment. Berg LLC , Boston, Mass. Product: BPM 31543...
Items per page:
1 - 1 of 1